'Navigate' - Low-risk, localised prostate cancer
Recently diagnosed with low-risk prostate cancer? Want to find out more about your treatment options?
Research shows that men with low-risk prostate cancer do not always fully understand their treatment options and the benefits and risks of each option. This can sometimes create a feeling of worry or being overwhelmed about what to do. The trial is testing a website to help men understand their diagnosis and make informed decisions about their treatment options. Treatment options include active surveillance (close monitoring), surgery, radiotherapy and brachytherapy.
The Navigate website has been developed by a team of experts and men with first-hand experience of prostate cancer. Included are over 40 videos of men, partners, oncologists, urologists and specialist prostate nurses to provide a range of perspectives and personal experiences.
Is this study suitable for you?
You may be eligible to participate if:
- You have been diagnosed with low risk or localised prostate cancer within the last three months.
- You are still deciding on your treatment options and one option includes Active Surveillance (to be confirmed with your treating doctor).
- You have access to the internet and are able to meet the study requirements.
What will happen if you decide to take part?
If you decide to participate, Peter MacCallum Cancer Centre will provide you access to one (of two) prostate cancer websites. You can take as much or as little time as you like reading through the information.
Both websites provide information about low-risk prostate cancer and the different treatment options available.
We will ask you to complete four online questionnaires over a six month period. Each questionnaire will take about 15-20 minutes to complete (1-2 hours of your time in total).
We would also like to collect your Medicare information if you give us your permission.
What are the possible benefits of taking part?
Peter MacCallum Cancer Centre hope the information provided will help you to feel informed about your diagnosis and the treatment options available to you, and also hope the findings from this study will help create resources that are useful for other men making similar decisions in the future.
Is participation voluntary?
Yes. Participation in this study is completely voluntary, and you can withdraw at any time.
Any decision you make will not affect your medical care in any way, or your relationship with your healthcare team.
Partners are also welcome to join the study.
Register your interest
To register your interest and find out if you are eligible, visit www.navigateprostate.com.au.
Peter MacCallum Cancer Centre will contact you within 2 business days to discuss the study and your eligibility further.
Patients are also recruited through urology outpatient clinics at Peter MacCallum Cancer Centre, Cabrini Health, Austin Health, Alfred Health and Western Health.
This is a National Health and Medical Research Council funded project (sponsored by Swinburne University) and meets the principles set out by the National Statement on Ethical Conduct in Human Research.